Caplyta Reduces Acute Bipolar Mania in Phase 3
Johnson and Johnson reported that once-daily lumateperone 42 mg reduced acute manic symptoms in bipolar I disorder in the randomized three-week Study 451. The placebo-adjusted Young Mania Rating Scale improvement was 4.8 points at…
